Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice

Wiley - Tập 2 Số 1 - 2012
Lucie Mondoulet1, Vincent Dioszeghy1, Emilie Puteaux1, Mélanie Ligouis1, Véronique Dhelft1, Franck Letourneur2, Christophe Dupont3, Pierre‐Henri Benhamou1
1DBV Technologies, Green Square, Bagneux, France
2Institut Cochin, Université Paris Descartes INSERM‐U567 Paris France
3Hôpital Necker Enfants Malades, Université Paris Descartes, Paris, France

Tóm tắt

AbstractBackgroundEpicutaneous immunotherapy (EPIT) on intact skin with an epicutaneous delivery system has already been used in preclinical and clinical studies. In epicutaneous vaccination and immunotherapy, the stripping of skin before application of the allergen is suggested to facilitate the passage of allergen through immune cells.ObjectivesThe aim of this study was to compare the immunological response induced by EPIT performed on intact and stripped skin in a mouse model of peanut allergy.MethodsAfter oral sensitization with peanut and cholera toxin, BALB/c mice were epicutaneously treated using an epicutaneous delivery system (Viaskin® (DBV Technologies, Paris) applied either on intact skin or on stripped skin. Following EPIT, mice received an exclusive oral peanut regimen, aimed at triggering esophageal and jejunal lesions. We assessed eosinophil infiltration by histology, mRNA expression in the esophagus, antibody levels and peripheral T‐cell response.ResultsEPIT on intact skin significantly reduced Th2 immunological response (IgE response and splenocyte secretion of Th2 cytokines) as well as esophageal eosinophilia (2.7 ± 0.9, compared to Sham 19.9 ± 1.5, p < 0.01), mRNA expression of Th2 cytokines in tissue and intestinal villus sub‐atrophia (2.9 ± 0.2 vs Sham, 2.1 ± 0.2, p < 0.05). By contrast, EPIT on stripped skin reinforced Th2 systemic immunological response as well as eosinophil infiltration (26.8 ± 15.1), mRNA expression of Th2 cytokines and duodenal villus/crypt‐ratio (2.4 ± 0.3).ConclusionsEpicutaneous allergen‐specific immunotherapy needs the integrity of superficial layers of the stratum corneum to warranty safety of treatment and to induce a tolerogenic profile of the immune response.

Từ khóa


Tài liệu tham khảo

10.1016/j.jaci.2010.02.029

10.4049/jimmunol.1003134

10.1111/j.1365-2222.2009.03430.x

10.1159/000321822

10.1371/journal.pone.0031967

Glenn GM, 1998, Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge, J Immunol, 161, 3211, 10.4049/jimmunol.161.7.3211

10.1038/36014

10.1016/j.jaci.2009.07.019

10.1067/mai.2000.107395

10.1111/j.1365-2567.2004.01989.x

10.1111/j.1365-2222.2005.02260.x

10.1111/j.1365-2567.2006.02401.x

10.1172/JCI1647

10.1080/00365520600815639

10.1086/422694

10.1056/NEJMoa013536

10.1016/j.jaci.2008.12.014

10.1136/bmj.313.7052.300

10.1016/j.jaci.2011.08.036

Dioszeghy V, 2011, Epicutaneous immunotherapy requires intact skin and not stripped skin to properly activate and mature dendritic cells toward induction of desensitization (EAACI Congress, PS 1326), Allergy, 66, 482

10.1016/j.jaci.2005.08.033

10.1073/pnas.0801532105

10.1016/j.jaci.2010.08.041

10.1073/pnas.0604575103

10.1111/j.1398-9995.2012.02798.x

10.1172/JCI59725

Thông tin
Thông tin xuất bản

Wiley

Tập 2 Số 1

Thông tin tác giả